The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Viscosupplementation is a medical treatment for knee osteoarthritis during which lubricating fluid is injected into the knee joint to reduce pain symptoms.
The global Orthopedic Hyaluronic Acid Viscosupplementation market was valued at US$ 1822 million in 2023 and is anticipated to reach US$ 2329.4 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
This report aims to provide a comprehensive presentation of the global market for Orthopedic Hyaluronic Acid Viscosupplementation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orthopedic Hyaluronic Acid Viscosupplementation.
Report Scope
The Orthopedic Hyaluronic Acid Viscosupplementation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orthopedic Hyaluronic Acid Viscosupplementation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orthopedic Hyaluronic Acid Viscosupplementation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- Sanofi
- Anika Therapeutics
- Seikagaku
- Zimmer Biomet
- Bioventus
- Ferring
- LG Chem
- Freda
- Haohai Biological
- Shanghai Jingfeng
Segment by Type
- Single Injection
- Three Injection
- Five Injection
Segment by Application
- Hospitals
- Clinics
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orthopedic Hyaluronic Acid Viscosupplementation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orthopedic Hyaluronic Acid Viscosupplementation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Orthopedic Hyaluronic Acid Viscosupplementation Market Overview
1.1 Product Overview and Scope of Orthopedic Hyaluronic Acid Viscosupplementation
1.2 Orthopedic Hyaluronic Acid Viscosupplementation Segment by Type
1.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Value Comparison by Type (2024-2030)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Orthopedic Hyaluronic Acid Viscosupplementation Segment by Application
1.3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size Estimates and Forecasts
1.4.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue 2019-2030
1.4.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales 2019-2030
1.4.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Orthopedic Hyaluronic Acid Viscosupplementation Market Competition by Manufacturers
2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Manufacturers (2019-2024)
2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Average Price by Manufacturers (2019-2024)
2.4 Global Orthopedic Hyaluronic Acid Viscosupplementation Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orthopedic Hyaluronic Acid Viscosupplementation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orthopedic Hyaluronic Acid Viscosupplementation, Product Type & Application
2.7 Orthopedic Hyaluronic Acid Viscosupplementation Market Competitive Situation and Trends
2.7.1 Orthopedic Hyaluronic Acid Viscosupplementation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orthopedic Hyaluronic Acid Viscosupplementation Players Market Share by Revenue
2.7.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orthopedic Hyaluronic Acid Viscosupplementation Retrospective Market Scenario by Region
3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2019-2030
3.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2019-2024
3.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2025-2030
3.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region: 2019-2030
3.3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region: 2019-2024
3.3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region: 2025-2030
3.4 North America Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.4.1 North America Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2019-2030)
3.4.3 North America Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.5.1 Europe Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2019-2030)
3.5.3 Europe Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.6.1 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2019-2030)
3.6.3 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.7.1 Latin America Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2019-2030)
3.7.3 Latin America Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.8.1 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2019-2030)
3.8.3 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2019-2030)
4.1.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2019-2024)
4.1.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2025-2030)
4.1.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Type (2019-2030)
4.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type (2019-2030)
4.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type (2019-2024)
4.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type (2025-2030)
4.2.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Type (2019-2030)
4.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Price by Type (2019-2030)
5 Segment by Application
5.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2019-2030)
5.1.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2019-2024)
5.1.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2025-2030)
5.1.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Application (2019-2030)
5.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application (2019-2030)
5.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application (2019-2024)
5.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application (2025-2030)
5.2.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Application (2019-2030)
5.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Anika Therapeutics
6.2.1 Anika Therapeutics Corporation Information
6.2.2 Anika Therapeutics Description and Business Overview
6.2.3 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.2.5 Anika Therapeutics Recent Developments/Updates
6.3 Seikagaku
6.3.1 Seikagaku Corporation Information
6.3.2 Seikagaku Description and Business Overview
6.3.3 Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.3.5 Seikagaku Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Bioventus
6.5.1 Bioventus Corporation Information
6.5.2 Bioventus Description and Business Overview
6.5.3 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.5.5 Bioventus Recent Developments/Updates
6.6 Ferring
6.6.1 Ferring Corporation Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.6.5 Ferring Recent Developments/Updates
6.7 LG Chem
6.6.1 LG Chem Corporation Information
6.6.2 LG Chem Description and Business Overview
6.6.3 LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.7.5 LG Chem Recent Developments/Updates
6.8 Freda
6.8.1 Freda Corporation Information
6.8.2 Freda Description and Business Overview
6.8.3 Freda Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Freda Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.8.5 Freda Recent Developments/Updates
6.9 Haohai Biological
6.9.1 Haohai Biological Corporation Information
6.9.2 Haohai Biological Description and Business Overview
6.9.3 Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.9.5 Haohai Biological Recent Developments/Updates
6.10 Shanghai Jingfeng
6.10.1 Shanghai Jingfeng Corporation Information
6.10.2 Shanghai Jingfeng Description and Business Overview
6.10.3 Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
6.10.5 Shanghai Jingfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orthopedic Hyaluronic Acid Viscosupplementation Industry Chain Analysis
7.2 Orthopedic Hyaluronic Acid Viscosupplementation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orthopedic Hyaluronic Acid Viscosupplementation Production Mode & Process
7.4 Orthopedic Hyaluronic Acid Viscosupplementation Sales and Marketing
7.4.1 Orthopedic Hyaluronic Acid Viscosupplementation Sales Channels
7.4.2 Orthopedic Hyaluronic Acid Viscosupplementation Distributors
7.5 Orthopedic Hyaluronic Acid Viscosupplementation Customers
8 Orthopedic Hyaluronic Acid Viscosupplementation Market Dynamics
8.1 Orthopedic Hyaluronic Acid Viscosupplementation Industry Trends
8.2 Orthopedic Hyaluronic Acid Viscosupplementation Market Drivers
8.3 Orthopedic Hyaluronic Acid Viscosupplementation Market Challenges
8.4 Orthopedic Hyaluronic Acid Viscosupplementation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
